72 / 100

Dr. Lorena García Hevia | Nanomedicine | Best Researcher Award

Dr. Lorena García Hevia, Universidad de Cantabria, Spain

👩‍🔬 Dr. Lorena García Hevia, a distinguished biologist and established researcher at the University of Cantabria, Spain, specializes in nanomedicine and molecular biology. Awarded the prestigious Ramon y Cajal contract, she holds expertise in cancer-focused nanotechnology, earning recognition for her exceptional doctoral thesis. With an international research background, including roles in the USA, Portugal, and Italy, she contributes significantly to cancer treatment advancements. Leading multiple projects and supervising theses, Dr. García Hevia actively engages in research networks, conferences, and science outreach events, emphasizing her commitment to scientific excellence and knowledge dissemination. 🌐🔬🏆

🎓 Education & Experience:

📜 R3 certified established researcher, young at 40 years old. 🎓 Master’s (2011) and Ph.D. (2016) in Molecular Biology and Biomedicine from the University of Cantabria (UC). 🏆 “Premio Extraordinario” and “Premio Juan María Parés” for the best doctoral thesis in Health Sciences at UC. 🌐 International experience in nanomedicine research at institutions in Europe and the USA. 🌍 Positions at the University of Oklahoma, International Nanotechnology Laboratory (INL) in Portugal, and The Biorobotics Institute in Italy. 🧪 Specialization in cancer research using gold nanoparticles and magnetic nanostructures.

🏆 Achievements:

🎗️ Awarded the prestigious Spanish Ramon y Cajal contract. 🤝 Associated researcher at Valdecilla Research Institute (IDIVAL). 🏆 Leadership role as co-chair of the organizing committee for the NALS 2022 Congress. 📄 31 publications, h-index: 14, 506 citations (Scopus).

🔬 Areas of Research:

🩺 Nanomedicine. 🧬 Molecular and Cell Biology.

🚀 Research & Development Contributions:

🌐 Involved in over 15 National and International projects. 🏅 Leading four projects, including a National Health project and a Strategic Project for Ecological and Digital Transition. 🎓 Supervising 5 Ph.D. theses, 3 Master final projects, and 6 Degree final projects. 🌐 Participation in 35+ National and International congresses. 🤝 Membership in various research networks and associations, including NANOCARE 2.0, Spanish Association for Cancer Research, European Association for Cancer Research, Controlled Release Society, and Research Network NANOMED Spain.

💬 Communication and Outreach:

🌍 Engaged in dissemination activities like “International Day of Women in Science,” “CONOCELAS,” and “European Research Night”. 🤝 Leadership role as co-chair of the organizing committee for the NALS 2022 Congress showcases dedication to community involvement and collaboration.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 659.
  • Citations – 659.
  • h-index – 16.
  • Documents – 45.

A prolific researcher making meaningful contributions to the academic world!

🔬 Research Focus:

Dr. Lorena García Hevia’s groundbreaking research in nanomedicine revolves around developing innovative multifunctional nanocarriers. Her work includes the design of graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug delivery, cited 71 times in 2018. She delves into the impact of nano-ZnO on cytoskeletal structures, triggering cell necrosis (71 citations, 2016). Exploring manganese-based nanostructures as responsive MRI contrast agents (66 citations, 2019), her contributions extend to the therapeutic realm, inhibiting tumor progression (39 citations, 2016) and cancer cell migration (35 citations, 2015). Her research reflects a diverse portfolio, from investigating nanotube interactions with microtubules (32 citations, 2014) to the recent synergy of magnetic lipid nanovehicles for controlled thermal release and non-invasive monitoring in melanoma (27 citations, 2022). 🌐🔬

Lorena García Hevia | Nanomedicine | Best Researcher Award

You May Also Like